339 related articles for article (PubMed ID: 36840654)
1. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
Fu R; Xianyu Y
Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
[TBL] [Abstract][Full Text] [Related]
2. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
[TBL] [Abstract][Full Text] [Related]
3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets.
Su W; Li J; Ji C; Chen C; Wang Y; Dai H; Li F; Liu P
Nano Res; 2023 Mar; ():1-14. PubMed ID: 37359078
[TBL] [Abstract][Full Text] [Related]
5. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas Systems towards Next-Generation Biosensing.
Li Y; Li S; Wang J; Liu G
Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
[TBL] [Abstract][Full Text] [Related]
7. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
[TBL] [Abstract][Full Text] [Related]
9. Nano-immunosorbent assay based on Cas12a/crRNA for ultra-sensitive protein detection.
Zhao Q; Pan Y; Luan X; Gao Y; Zhao X; Liu Y; Wang Y; Song Y
Biosens Bioelectron; 2021 Oct; 190():113450. PubMed ID: 34197999
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
Wei C; Lei X; Yu S
ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection.
Huang Z; Liu S; Pei X; Li S; He Y; Tong Y; Liu G
Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290917
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas12a System for Biosensing and Gene Regulation.
Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas12a-Based Nucleic Acid Amplification-Free DNA Biosensor via Au Nanoparticle-Assisted Metal-Enhanced Fluorescence and Colorimetric Analysis.
Choi JH; Lim J; Shin M; Paek SH; Choi JW
Nano Lett; 2021 Jan; 21(1):693-699. PubMed ID: 33346665
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas based virus detection: Recent advances and perspectives.
Yin L; Man S; Ye S; Liu G; Ma L
Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
[TBL] [Abstract][Full Text] [Related]
15. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
Tan JJ; Peng YZ; Huang GT
Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
[TBL] [Abstract][Full Text] [Related]
16. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
Aman R; Mahas A; Mahfouz M
ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
[TBL] [Abstract][Full Text] [Related]
17. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
18. Y-shaped DNA nanostructures assembled-spherical nucleic acids as target converters to activate CRISPR-Cas12a enabling sensitive ECL biosensing.
Mei-Ling L; Yi L; Mei-Ling Z; Ying Z; Xiao-Jing H
Biosens Bioelectron; 2022 Oct; 214():114512. PubMed ID: 35780537
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas system manipulating nanoparticles signal transduction for cancer diagnosis.
Guo Y; Guo L; Su Y; Xiong Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1851. PubMed ID: 36199268
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/cas systems redefine nucleic acid detection: Principles and methods.
Wang M; Zhang R; Li J
Biosens Bioelectron; 2020 Oct; 165():112430. PubMed ID: 32729545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
